Cargando…
Synaptogenic effect of APP-Swedish mutation in familial Alzheimer’s disease
Mutations in β-amyloid (Aβ) precursor protein (APP) cause familial Alzheimer’s disease (AD) probably by enhancing Aβ peptides production from APP. An antibody targeting Aβ (aducanumab) was approved as an AD treatment; however, some Aβ antibodies have been reported to accelerate, instead of ameliorat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894682/ https://www.ncbi.nlm.nih.gov/pubmed/36260691 http://dx.doi.org/10.1126/scitranslmed.abn9380 |